No Data
Morgan Stanley Maintains AbbVie(ABBV.US) With Buy Rating, Maintains Target Price $224
AbbVie (ABBV) Receives a Buy From Morgan Stanley
AbbVie Inks a Deal With Neomorph for Molecular Glue Degraders
Is AbbVie Stock a Buy?
Allergan Aesthetics Unveils New AA Signature Program and Immersive Booth at IMCAS World Congress 2025
Wall Street Today: S&P 500 Closes at Record, Trump Keeps Appearing on TV